Routine

Common drug eruptions

Dermatology · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Cutaneous adverse drug reactions, most commonly a benign morbilliform exanthem appearing 4-14 days after a new drug. Recognising red flags that herald severe reactions (SJS/TEN, DRESS) is the key physician skill.

Red flags

  • Refer or admit urgently if mucosal, blistering or systemic features suggest SJS/TEN or DRESS
  • Seek dermatology advice for diagnostic uncertainty, extensive involvement or a severe reaction

Assessment

Investigations

  • Largely clinical with a careful drug timeline
  • FBC (eosinophilia), LFTs and U&E (to detect DRESS) and observation for severe features
  • Skin biopsy if diagnostic uncertainty; patch/challenge testing later if needed

Management

  • Identify and stop the culprit drug
  • For a simple exanthem: emollients, topical corticosteroids and oral antihistamines for itch; most settle within 1-2 weeks
  • Document the reaction as an allergy and avoid re-exposure and cross-reacting agents

Disposition

Refer or admit urgently if mucosal, blistering or systemic features suggest SJS/TEN or DRESS.

Complications & pitfalls

  • Progression to Stevens-Johnson syndrome/TEN or DRESS, secondary bacterial infection of excoriated skin, and post-inflammatory hyper- or hypopigmentation

Exam pearls

  • A morbilliform rash with fever, facial oedema, eosinophilia and deranged LFTs is DRESS, not a simple exanthem - stop the drug and monitor closely, as it can evolve and relapse over weeks.
  • Monitoring & follow-up: Watch for evolving red-flag features over several days and monitor bloods if DRESS is suspected. Update the allergy record clearly and give the patient a written list of drugs to avoid.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.